Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zenuzolac by Inovio Pharmaceuticals for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Zenuzolac is under clinical development by Inovio Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According...
Zenuzolac by Inovio Pharmaceuticals for Diabetic Nephropathy: Likelihood of Approval
Zenuzolac is under clinical development by Inovio Pharmaceuticals and currently in Phase I for Diabetic Nephropathy. According to GlobalData, Phase...
Zenuzolac by Inovio Pharmaceuticals for Inflammation: Likelihood of Approval
Zenuzolac is under clinical development by Inovio Pharmaceuticals and currently in Phase I for Inflammation. According to GlobalData, Phase I...